Eli Lilly (LLY) revenue

Revenue · fiscal 2025
$65.18B

Eli Lilly (LLY) reported revenue of $65.18B in fiscal 2025 (the year ended December 31, 2025). That is 44.7% higher than the $45.04B of fiscal 2024. Figures as of 17 Nov 2026, 17:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$65.18B
Change on fiscal 2024
+44.7%
Growth, 5 years
+21.6% a year
Growth, 10 years
+12.6% a year
Highest on record
$65.18Bfiscal 2025
Lowest on record
$18.63Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Eli Lilly revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 21.6% a year; over ten years the rate was 12.6% a year. Across the 19 fiscal years on record (2007–2025), the highest was $65.18B in fiscal 2025 and the lowest $18.63B in fiscal 2007.

History · 19 fiscal years

Revenue by fiscal year

Eli Lilly revenue, year by year

Eli Lilly (LLY) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$65.18B 44.7% up
2024$45.04B 32.0% up
2023$34.12B 19.6% up
2022$28.54B 0.8% up
2021$28.32B 15.4% up
2020$24.54B 9.9% up
2019$22.32B 3.8% up
2018$21.49B 7.6% up
2017$19.97B 5.9% down
2016$21.22B 6.3% up
2015$19.96B 1.7% up
2014$19.62B 15.1% down
2013$23.11B 2.3% up
2012$22.60B 6.9% down
2011$24.29B 5.2% up
2010$23.08B 5.7% up
2009$21.84B 7.2% up
2008$20.37B 9.3% up
2007$18.63B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Eli Lilly and comparable companies
CompanyRevenueFiscal year
Eli Lilly LLY$65.18B2025
Johnson & Johnson JNJ$94.19B2025
AbbVie ABBV$61.16B2025
Merck & Co MRK$65.01B2025
UnitedHealth Group UNH$447.57B2025
Novartis NVS$56.67B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LLY

Eli Lilly, figure by figure

Eli Lilly (LLY) overview: price, valuation and scorecardAll health care companies by market value

Eli Lilly revenue: questions and answers

What is Eli Lilly's revenue?

Eli Lilly (LLY) reported revenue of $65.18B in fiscal 2025 (the year ended December 31, 2025). That is 44.7% higher than the $45.04B of fiscal 2024.

What is the growth rate of Eli Lilly's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 21.6% a year; over ten years the rate was 12.6% a year.

What are the highest and lowest revenue figures on record for Eli Lilly?

Across the 19 fiscal years on record (2007–2025), the highest was $65.18B in fiscal 2025 and the lowest $18.63B in fiscal 2007.

How is Eli Lilly's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Eli Lilly (LLY) revenue”, data as of 17 November 2026. https://funkfolio.com/stock/LLY/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.